Chuck Grassley actually said...

"The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices."

"In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price."

"I believe it is our duty to understand how the pharmaceutical supply chain is working, and what we can do to improve it."

"We are preached at by corporate elitists that think that we ought to be carbon-neutral by some arbitrary dates."